Latest Features & Opinion

Hemicrania Continua: Diagnosis and Treatment

Hemicrania continua, one of the trigeminal primary headaches, causes intense unilateral pain for ≥3 months.

Navigating Social Media Issues in Medical ...

Issues that affect employees in all industries are compounded by a unique set of additional concerns that affect employees of medical practices.

Striking a Balance Between Opioid Surveillance ...

Big data has enabled public health authorities to identify doctor-shopping patients and those who needed treatment for opioid abuse. The trade-off, however, could be patient and provider privacy.

Detox vs Medication-Assisted Treatment for Opioid ...

Based on current evidence, there is a strong consensus that medication-assisted treatment is recommended over detoxification in the treatment of opioid use disorder during pregnancy.

The Opioid System: The Foundation for ...

The opioid system is responsible for social pain and reward in the brain; therefore, understanding its underpinnings may help clinicians manage patients with depression and suicidal ideation.

The Role of Psychological Factors in ...

Up to 85% of amputees experience phantom limb pain: sensations in the missing limb that patients may describe as burning, cramping, tingling, itching, stabbing, throbbing, or a feeling of "pins and needles."

Managing Comorbid Opioid and Alcohol Use ...

When alcohol and opioid addiction occur together, managing them concomitantly becomes challenging. Whereas some patients may not need medication for alcohol addiction, opioid abuse does require pharmacotherapy.

Comorbid Bipolar Disorder and Substance Abuse: ...

Bipolar disorder is often comorbid with substance use disorders, with alcohol being the top substance. Clinicians should take a thorough history to uncover substance use disorder because it will guide the management of both disorders.

Descriptive, Predictive Data at Odds in ...

Because they're busy looking in different directions, "innocent until proven guilty" and "first, do no harm" don't always get along.

Pediatric Migraine and Obesity: What We ...

Data in children do support an association between pediatric obesity and headache disorders in general, but more research is needed to confirm the association specifically with pediatric migraine.

Abuse-Deterrent Opioid Formulations: Barriers to Broader ...

Abuse-deterrent opioid formulations have not yet been widely accepted despite their proposed value in reducing opioid abuse and related mortality. Many of the current barriers to broader use are related to their higher cost compared with conventional formulations.
Practice Management

Mentoring Women in the #MeToo Era: Expert Roundtable

Mentoring Women in the #MeToo Era: Expert Roundtable

Despite record numbers of women working in medicine, instances of gender discrimination and sexual harassment continue to proliferate.

Opioid Addiction

Perioperative Pain Management in Patients With Opioid Use Disorder

Perioperative Pain Management in Patients With Opioid Use Disorder

The perioperative management of pain in patients with opioid use disorders presents multiple challenges to clinicians. A recent review offered clinical guidance for various subgroups of these individuals.

Migraine & Headache

Surgical, Nonsurgical Treatments for Chronic Migraine: Evidence and Relevancy

Surgical, Nonsurgical Treatments for Chronic Migraine: Evidence and Relevancy

There are many procedural treatments for migraine that are effective and safe, including peripheral nerve blocks, trigger point injections, botulinum toxin injections, and sphenopalatine ganglion blocks.

Geriatric Pain Management

Experts Offer Tips on Integrating Medical Marijuana Into Geriatric Practice

Experts Offer Tips on Integrating Medical Marijuana Into Geriatric Practice

A study by the National Survey of Drug Use and Health (NSDUH) found that from 2002-2014 the proportion of adults aged 50 to 64 who reported cannabis use in the past year more than tripled from 2.9% to 9.0%. Among adults age 65 or older, there was more than a ten-fold increase (from 0.2% to 2.1%).

Opioid Addiction

Abuse-Deterrent Opioid Formulations: Barriers to Broader Use

Abuse-Deterrent Opioid Formulations: Barriers to Broader Use

Abuse-deterrent opioid formulations have not yet been widely accepted despite their proposed value in reducing opioid abuse and related mortality. Many of the current barriers to broader use are related to their higher cost compared with conventional formulations.

Migraine & Headache

Approved in Migraine, CGRP Antagonists Also Promising in Cluster Headache

Approved in Migraine, CGRP Antagonists Also Promising in Cluster Headache

Cluster headache and migraine are distinct primary headache disorders that are associated with substantial pain and disability.

Drug Lookup

Search our drug information database which contains an extensive list of pain drugs.

Browse drugs by:

Brand Generic Disease

Sign Up for Free e-Newsletters